Search

everythinglearnresearchcommunity

for

Search:↓

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Gray hair can potentially be reversed, leading to new treatments.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Stem cells show promise for hair regrowth, but challenges remain.

Baricitinib treatment for alopecia universalis can cause hair regrowth with unexpected whitening.

Psoriasis worsens in winter in India due to less sunlight and dry skin, needing personalized treatment.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Severe alopecia areata greatly impacts quality of life, mental health, and daily activities.

Upadacitinib may effectively treat alopecia areata without side effects.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Baricitinib may effectively treat oral lichen planus.

The skin microbiome helps heal wounds and can be targeted to improve healing.

SH-MSCs gel can effectively treat alopecia by increasing IL-10 and decreasing TNF-α gene expression.

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

Effective PCOS treatments require targeting specific signaling pathways.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

JAGGED1 could help regenerate tissues for bone loss and heart damage if delivered correctly.

The mTOR signaling pathway is crucial for hair health and targeting it may lead to new hair loss treatments.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.